Cargando…
Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis
BACKGROUND: Integrase strand transfer inhibitors (INSTIs) are highly efficacious and well tolerated antiretrovirals with fewer adverse side-effects relative to other classes of antiretrovirals. The use of INSTIs raltegravir, elvitegravir, and dolutegravir has increased dramatically over recent years...
Autores principales: | Kamelian, Kimia, Lepik, Katherine J, Chau, William, Yip, Benita, Zhang, Wendy W, Lima, Viviane Dias, Robbins, Marjorie A, Woods, Conan, Olmstead, Andrea, Joy, Jeffrey B, Barrios, Rolando, Harrigan, P Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419991/ https://www.ncbi.nlm.nih.gov/pubmed/30895202 http://dx.doi.org/10.1093/ofid/ofz060 |
Ejemplares similares
-
The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada
por: Zhu, Jielin, et al.
Publicado: (2019) -
Motor vehicle incidents in postgraduate trainees in British Columbia
por: Cassidy, Louise F, et al.
Publicado: (2021) -
Application and Validation of Case-Finding Algorithms for Identifying Individuals with Human Immunodeficiency Virus from Administrative Data in British Columbia, Canada
por: Nosyk, Bohdan, et al.
Publicado: (2013) -
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting
por: Greenberg, Lauren, et al.
Publicado: (2022) -
Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, Canada
por: Munasinghe, Lalani L., et al.
Publicado: (2023)